Valuation: Abbott Laboratories

Market Cap 171B 854B 153B 142B 129B 244B 16,526B 245B 1,711B 669B 8,405B 641B 627B 27,019B P/E 2026 *
28.9x
P/E 2027 * 22.4x
Enterprise Value 195B 974B 174B 162B 147B 278B 18,842B 280B 1,951B 762B 9,583B 731B 715B 30,805B EV / Sales 2026 *
3.88x
EV / Sales 2027 * 3.52x
Free-Float
86.16%
Yield 2026 *
2.6%
Yield 2027 * 2.78%
1 day-16.78%
1 week-3.02%
Current month-3.02%
1 month-8.20%
3 months-0.19%
6 months-5.91%
Current year-27.82%
1 week 40.7
Extreme 40.7
42.65
1 month 40.7
Extreme 40.7
50.01
Current year 33.5
Extreme 33.5
57.5
1 year 33.5
Extreme 33.5
61.08
3 years 33.5
Extreme 33.5
67.65
5 years 33.5
Extreme 33.5
67.65
10 years 10.4
Extreme 10.403333
67.65
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
-16.78%-3.02% - - 170B
+0.58%-0.10%-25.78%+1.91% 170B
-1.81%-0.90%-13.04%+12.34% 111B
-1.01%+0.00%-25.41%+3.59% 107B
-0.03%+0.72%-46.94%-10.61% 75.95B
+0.28%+5.66%+2.77%+72.56% 60.37B
+0.74%+7.44%+12.33%+67.73% 53.53B
-0.08%+0.65%-6.42%-31.35% 49.11B
-1.70%-2.97%-19.23%+13.61% 40.6B
+1.09%-2.31%+27.67%+1.30% 31.47B
Average -1.47%+1.08%-10.45%+14.56% 77.67B
Weighted average by Cap. -2.99%+0.85%-16.46%+11.93%

Financials

2026 *2027 *
Net sales 50.2B 251B 44.85B 41.85B 38.01B 71.59B 4,856B 72.12B 503B 196B 2,470B 188B 184B 7,939B 54.53B 273B 48.72B 45.45B 41.29B 77.76B 5,275B 78.34B 546B 213B 2,683B 205B 200B 8,624B
Net income 6.21B 31.07B 5.55B 5.18B 4.7B 8.86B 601B 8.93B 62.23B 24.31B 306B 23.32B 22.82B 982B 7.89B 39.48B 7.05B 6.58B 5.98B 11.26B 764B 11.34B 79.07B 30.89B 388B 29.63B 28.99B 1,248B
Net Debt 23.94B 120B 21.39B 19.96B 18.13B 34.14B 2,316B 34.39B 240B 93.69B 1,178B 89.87B 87.93B 3,786B 20.96B 105B 18.73B 17.47B 15.87B 29.89B 2,027B 30.11B 210B 82.02B 1,031B 78.68B 76.98B 3,314B
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-10-07 R$41.40 +1.57% 237
26-10-06 R$40.76 -2.67% 588
26-10-05 R$41.88 -1.34% 678
26-10-02 R$42.45 +0.21% 57
26-10-01 R$42.36 -0.77% 89
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
98.73USD
Average target price
120.72USD
Spread / Average Target
+22.27%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories